Honesty Management
Yongsheng Biotechnology places a high priority on corporate governance and is committed to sustainable growth and ethical business practices.
Implementation of the Integrity in Business Policy
- The Company has established the “Corporate Integrity Code” and the “Code of Ethical Conduct,” which require all members of the Company—including the Board of Directors and management—to actively implement integrity policies and strengthen awareness-raising efforts among employees.
- In August 2024, we conducted corporate governance and securities regulations awareness sessions for directors and assisted in arranging for directors to attend courses related to corporate governance and ethical business practices.Integrity Code training is provided during new employee orientation, ensuring that policies related to integrity in business operations are communicated and enforced from the very start of onboarding, so that employees understand the company’s integrity policies and their associated guidelines. In addition, corporate social responsibility training sessions are held periodically to clearly articulate employees’ rights and obligations and to ensure their understanding of the integrity policies.
- The Company has established the “Insider Trading Prevention Management Procedures,” which clearly define the scope of application, the parties subject to these regulations, and the relevant operational procedures. These procedures are designed to prevent the Company’s directors, managers, and other insiders from inadvertently or intentionally violating insider trading regulations due to a lack of familiarity with applicable laws and regulations, thereby safeguarding the interests of investors and the Company.
- On November 29, 2024, the Company conducted an educational session on insider trading for all employees, with a total of 64 participants. The session covered the following topics: insider shareholdings and reporting requirements; the elements and common patterns of short-term trading; the elements of insider trading; legal liabilities; and relevant case studies.
- As part of its annual training program on the prohibition of insider trading, the Company reminds directors that they are prohibited from trading their shares during the blackout periods—30 days prior to the announcement of annual financial reports and 15 days prior to the announcement of quarterly financial reports.
- Our company has established reporting channels, including an email reporting option.
Complaints Email: law@stemcytebio.com
Complaints Email: